Hartree Partners’s Cano Health, Inc. CANO Stock Holding History

Hartree Partners’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-950	Closed	-$1.27M	–	192
2020 Q4	$1.27M	Buy	+950	New	+$1.09M	0.29%	43

Other funds holding CANO

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Hartree Partners's CANO Position: Q1 2021 in Review

Hartree Partners sold out of Cano Health, Inc. (CANO) in Q1 2021, closing a stake of 950 shares — an estimated $1.27M sold.

Hartree Partners first reported a position in CANO in Q4 2020 and held it in 1 quarter. The position peaked at $1.27M in Q4 2020. 71 funds tracked by Wall St. Rank hold CANO as of Q1 2021.

Hartree Partners reported no remaining Cano Health, Inc. position as of Q1 2021 after selling out during the quarter.
Hartree Partners sold 950 Cano Health, Inc. shares in Q1 2021, an estimated $1.27M.
Hartree Partners first reported a position in Cano Health, Inc. in Q4 2020 and held it in 1 quarter.
Hartree Partners's Cano Health, Inc. position peaked at $1.27M in Q4 2020.
71 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2021.

Based on Hartree Partners's 13F filing for Q1 2021, filed 14 May 2021.